{"status":"success","data":{"title":"NSAIDs and Upper GI Bleed","slug":"NSAID-GI-bleed","tags":["Ibuprofen","Diclofenac","Meloxicam","Indomethacin","Ketoprofen","Naproxen","Piroxicam","Ketorolac","Celecoxib","Aceclofenac","Rofecoxib"],"collection":["gastroenterology","pharmacology"],"content":"\n# NSAIDs and Upper GI Bleed\n\n-   Stomach and platelets have much more COX-1 receptors than COX-2 receptors.\n-   Below are statistics from systematic review on NSAIDs and upper GI complications(bleeding, perforation)\n\n**Ketorolac pearls**\n\n-   Has the highest upper GI complication RR (14.54)\n-   Before giving, first check that patients don't have a history of a GI bleed or peptic ulcer\n\n|                        |                    |                 |\n|------------------------|--------------------|-----------------|\n| **NSAID medication**   | **Relative risk of complication**     | **\\[95 % CI\\]** |\n| COX-1 Inhibitors (all) | 4.5                |  \\[3.82-5.31\\]  |\n|  - <span class=\"drug\">Ibuprofen</span>           | 2.69               | \\[2.17-3.33\\]   |\n|  - <span class=\"drug\">Diclofenac</span>\\*        | 3.98               | \\[3.36-4.72\\]   |\n|  - <span class=\"drug\">Meloxicam</span>\\*         | 4.15               | \\[2.59-6.64\\]   |\n|  - <span class=\"drug\">Indomethacin</span>\\*      | 5.40               | \\[4.16-7.00\\]   |\n|  - <span class=\"drug\">Ketoprofen</span>\\*        | 5.57               | \\[3.94-7.87\\]   |\n|  - <span class=\"drug\">Naproxen</span>\\*          | 5.63               | \\[3.83-8.28\\]   |\n|  - <span class=\"drug\">Piroxicam</span>           | 9.94               | \\[5.99-16.50\\]  |\n|  - <span class=\"drug\">Ketorolac</span>           | 14.54              | \\[5.87-36.04\\]  |\n| COX-2 Inhibitors (all) | 1.88               | \\[0.96-3.71\\]   |\n|  - <span class=\"drug\">Celecoxib</span>           | 1.42               | \\[0.85-2.37\\]   |\n|  - <span class=\"drug\">Aceclofenac</span>         | 1.44               | \\[0.65-3.2\\]    |\n|  - <span class=\"drug\">Rofecoxib</span>           | 2.12               | \\[1.59-2.84\\]   |\n\n*\\* = Estimated relative risk*\n\n## Risk Factors for Upper GI Complication\n\n1.  <span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2488d35d3ae92e001f47\">Longer drug half-life</span>\n2.  Slow-release formulation\n3.  <span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2488d35d3ae92e001f48\">Dual inhibition of COX-1 and COX-2 isoenzymes</span> \n\nRelative risk is greatest when first starting medication (&lt; 30 days)\n\n## References\n\n-   [Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010 Jun;62(6):1592-601](http://www.ncbi.nlm.nih.gov/pubmed/?term=20178131)\n"}}